Optibiotix Health Share Discussion Threads

[slartybartfaster] 27/3/2018 21:24

'I also hope the most knowledgable, well researched, honest and open poster on any BB on ADVFN ain’t going anywhere!'

Who's that the JJ? Monkeysass?

[judijudi] 27/3/2018 19:38

I liked the RNS today
It was a confidence booster with great snippets of info

If folk can’t see what’s happening here tough shyte on them

I also hope the most knowledgable, well researched, honest and open poster on any BB on ADVFN ain’t going anywhere!
:)

I also we think we have in Mr OH the best CEO on AIM

I also think we have the best products and the biggest potential of any company on AIM

Game Changer!!

[paulhoodwinked] 27/3/2018 19:33

OK, i thought i would ask because that was my impression from a conversation i had with another PI. Pleased to see you about.

[elrico] 27/3/2018 19:07

Paul - where have I said I am not posting again, on any forum? I have said privately, I am limiting my time on them. I set the up the twitter group with another PI with the view of ignoring the BBMs, trolls and baiters and hopefully, bring OPTI to a wider audience over time. It's not a private group. For all I know all the trolls could have followed. For sure there are several NEW twitter accounts with no followers. However, thus far trolling, baiting, etc has not shown its ugly head. If it does, the offender(s) is blocked.

[paulhoodwinked] 27/3/2018 18:58

elrico, i thought you were done commenting here after setting up your secrete twitter group?

[elrico] 27/3/2018 18:46

TT - Fine Foods have pharma clients. Join the dot's.

[trotterstrading] 27/3/2018 18:38

Also note SoH comment re Pharmaceutical revenues? Fine foods deal related? Hmm

[john henry] 27/3/2018 18:30

Just as an example SYM is a company i invested in 4-6 weeks ago.Just like OPTI has potentially a huge future. share price has done nothing much over the years based on loads of jam but no scone.. However recent results showed a big up tick on revenue etc. Market is now taking notice.( share price moving to new 13 year highs.
OPTI will get to that inflection point eventually

[trotterstrading] 27/3/2018 18:29

I actually think SoH hinted at this without going so far as confirming.. his last comment re on track for revenues

[elrico] 27/3/2018 18:22

I put a case for a reach RNS to SOH last week. I didn't think it would fly, but it did. The only way SOH could have improved on the update, would be offering scope as to where the company is in terms of his stated hope for profitability in calendar 2018. This was never going to fly.

SOH: I think people misunderstand what you can say in an RNS. If we give any information on profitability it is seen by AIM as a forecast from the company and we have to then report to AIM on our progress on this. Any deviation outside forecast will have a large effect in the share price, one way or the other, and if more that 10% outside forecast will require a profits warning or trading update. Given the early commercialisation stage of the company where we are still building our deals and commercial pipeline their is a limited trading history on which to make a reliable forecast and the position is changing monthly, as we add new deals. We are not in the habit of guessing to promote share interest but are building the company to create sustainable long term shareholder value.


The aim of the RNS was to inform shareholders of the ongoing interest in our technology and products so they can make an informed judgement. As the RNS points out their are a number of deals in the pipeline, some with major retailers, others with corporates, which if we can conclude will have a significant impact on revenues. We are also opening up another channel to market which allows us to show our technology and products in a shop window.


Investors should see that as a company we are at the next stage of the companies development as we are starting to commercialise our products. We have a lot of interest, industry awards for our products, a number of early deals, and a broad deal pipeline with multiple retailer and corporate interest. The value of the company will be determined by how this interest transpires in terms of the volume, type of deal, and the scale of the revenues from these. However, as indicated in the RNS we would hope to see revenues of £5m-£10m from each of these divisions in the forthcoming years. If we achieve this each division should be worth in the region between £50-£100m

[trotterstrading] 27/3/2018 18:13

Exactly Rodders, what a plonker!

[imnotlong] 27/3/2018 17:08

Monkey, if you form a rival twitter group for what you would call the “non-rampers community” maybe all postings on this thread might dry up and everyone will be happy:)
And the tumbleweed can then blow by in silence whilst we wait for the RNS that will actually move the share price.

[imnotlong] 27/3/2018 16:57

Trotters it was not personal.
It has taken longer than I expected as well, hence my 9 months behind my expectations comment earlier today that JJ had issue with.
I said back in November I thought there would be buying opportunities in Jan 18.
This was Elrico’s reply then to me.

“IMHO I don't see any reasons to support your view we will have "plenty of top up opportunities well into jan 2018" because 2018 will dawn a renewed "big push" for SlimBiome, which will be driven with a new marketing and PR campaign by the same company that arguably brought Benecol into the commercial light.”

And yet when I point that I believe things are taking longer than expected I’m a deramper and negative. There are still buying opportunities now. And there will be until news comes.

[zebbo] 27/3/2018 16:52

On the plus side there has been good volume today. The problem is alot of people buy the news and will ditch these over the coming weeks as boredom sets in and the share price stagnates

I cannot see a sustained rise until hard numbers are presented on the balance sheet.

Apologies for sounding bearish, but it is getting tedious

[onedayrodders] 27/3/2018 16:44

imnotlong27 Mar '18 - 15:03 - 33652 of 33659 (Filtered)

crikey .. soon be more filtered here than not

[onedayrodders] 27/3/2018 16:43

How sad trolling back through someone's posts to gain a brownie point.

[judijudi] 27/3/2018 16:38

IMN
:)

TT,
What research?
All you do is ramp the guts out of it!
Oh and I'm long

[trotterstrading] 27/3/2018 16:28

Yes it's taken longer than expected, so what? At least I'm prepared to stick my neck on the block and add value with my research, what do you bring to the party accept negativity and snide comments?

[imnotlong] 27/3/2018 16:17

Trotters, re your comment about weak hands kicking themselves in the next few months....

Similar to this from over a year ago? Still just a bit a patience required.

“TrottersTrading - 23 Feb 2017 - 13:46:50 - 19987 of 33656 OptiBiotix - Better Science, Better Health. Better buy some! - OPTI
Nice one Primal. great response from SoH. Just a bit of patience required folks.

Make no mistake OPTI could be the share of 2017 IMHO”

[monkeywench1] 27/3/2018 15:38

The share doesn't need ramping.. But we will anyway. You cannot make this stuff up.

[trotterstrading] 27/3/2018 15:21

More weak hands cleared, boy are they going to be kicking themselves in a few months

[imnotlong] 27/3/2018 15:03

Good post Risky. It does beg the question why the share price is where it is considering the investment proposition is so compelling, even if somewhat complex. I’m sure by now some clever analysts working for II’s should have worked it out and decided to invest in a company that’s declares itself to be‘global leaders in targeted microbiome modulation and sweet prebiotics/fibres217;.

[riskybusiness1] 27/3/2018 13:49

This share does not need ramping, though it appears to require to give constant reminders to educate those to what it is the company is actually in the process of doing.To be fair the model is extraordinary. Opti is currently in limbo stage where it is transitioning to a commercial operation rather than a loss making R&D company. The market demands numbers though the company believes it to be too much of a risk to accurately forecast at this moment in time due to its growing list of clients that are launching products and paying at different times throughout the year. The bod have given an indication to the value of the deals multiple times now. The dots are all there to be joined.....hugely experienced bod with big contacts within industry, industry leaders set up as manufacturing partners, global industry leading events shortlisting Optis products for best technology/products, low cost £80-£90k cash burn, growing pipeline of license deals with the number of launches by these partners increasing globally and not to mention Skinbio which mitigates Optis need to ever raise another penny of cash to cover its costs before it becomes profitable. Times like these the brain can actually come in use.